Business Context and Reporting Period
This Form 8-K Current Report was filed by BioVie Inc. on April 25, 2018. The company, incorporated in Nevada, reported a material financial event occurring on the same date.
Key Financial Metrics
The filing discloses a new short-term convertible loan with the following terms:
- Principal Amount: $100,000
- Lender: Mr. Cuong Do (Member of the Board of Directors)
- Interest Rate: 10% simple interest
- Maturity Date: July 25, 2018
- Conversion Price: $0.025 per share
The filing text does not provide clear values for revenue, profit, cash flow, margins, total debt, or liquidity positions outside of this specific transaction.
Material Changes
The primary material change is the creation of a direct financial obligation of $100,000. This represents a new liability that must be repaid in full by July 25, 2018, unless converted into equity.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of general risks. The transaction includes specific conversion mechanics:
- BioVie has the right to convert the outstanding balance into stock at any time up to the maturity date.
- Mr. Do has the right to require conversion during the same period by forgoing all accrued interest.
Investor Verification Checklist
- Verify the total outstanding debt of BioVie Inc. as of April 25, 2018, to assess the impact of this new $100,000 obligation.
- Confirm the company's current cash position to evaluate its ability to repay the principal and interest by the July 25, 2018 maturity date.
- Review the company's authorized share count to determine the potential dilution if the loan is converted at $0.025 per share.
- Check for any subsequent filings regarding the repayment or conversion of this specific loan.